Ariana Sarin

CFO, AstraZeneca
· tracked since Jul 2026
Calls
1
Win Rate
0.0%
return
-9.6%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 1
Best Calls
No live winners yet
Worst Calls
AZN Long -9.6%
Most Mentioned
AZN ×1
Recent Calls
AZN Long 1 month ago
Win Rate 0% Long 1 Short 0
Win Rate
7d 0%
30d 0%
90d —
Average Return -9.6% Long Return -9.6% Short Return -
Average Return
7d -8.0%
30d -3.2%
90d —
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
AZN AstraZeneca PLC AstraZeneca PLC
Long
Jul 27
$171.73
-9.6%
AstraZeneca on track for $80B target
AstraZeneca is on track for its $80 billion revenue target by 2030, driven by oncology growth, diversified pipeline, and high phase 3 trial success rates; consensus revenue estimates are now above $80 billion, and the company plans sustained R&D investment to maintain 5% growth beyond 2030.
Pharma & Biotech
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Ariana Sarin has 1 trade ideas tracked on Buzzberg across 1 tickers since July 2026. Most covered: AZN.